H Plus Yangji Hospital
Seoul, South Korea
NCT Number: NCT06976489
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of PA-111 in healthy subjects.
Trial opening soon.
Get Notified19 year and older
All sexes
Interventional
Phase 1
Seoul, South Korea
The purpose of this study is to compare and evaluate the effect of food on the safety and pharmacokinetic profiles of PA-111 in healthy adult subjects.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PA-111 1Tab., Per Oral
Time frame: pre-dose (0hour) to 72hours
Cmax of PA-111
Time frame: pre-dose (0hour) to 72hours
AUCt of PA-111
Contact information is provided by the study sponsor or research team.
Addpharma Inc.
Industry
An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Food Effect on the Safety and the Pharmacokinetics of PA-111 in Healthy Adult Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07474649
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT07394517
Mixed Dyslipidemia
Barranquilla, Atlántico, Colombia
View Trial DetailsNCT07152873
Mixed Dyslipidemia
Seoul, South Korea
View Trial DetailsNCT07495514
Food Effect Study of AD-117, Mixed Dyslipidemia
Seoul, South Korea
View Trial Details